Evaluation of the performance of the APACHE III (Acute Physiology and Chronic Health Evaluation) ICU (intensive care unit) and hospital mortality models at the Princess Alexandra Hospital, Brisbane is reported. Prospective collection of demographic, diagnostic, physiological, laboratory, admission and discharge data of 5681 consecutive eligible admissions (1 January 1995 to 1 January 2000) was conducted at the Princess Alexandra Hospital, a metropolitan Australian tertiary referral medical/surgical adult ICU. ROC (receiver operating characteristic) curve areas for the APACHE III ICU mortality and hospital mortality models demonstrated excellent discrimination. Observed ICU mortality (9.1%) was significantly overestimated by the APACHE III model adjusted for hospital characteristics (10.1%), but did not significantly differ from the prediction of the generic APACHE III model (8.6%). In contrast, observed hospital mortality (14.8%) agreed well with the prediction of the APACHE III model adjusted for hospital characteristics (14.6%), but was significantly underestimated by the unadjusted APACHE III model (13.2%). Calibration curves and goodness-of-fit analysis using Hosmer-Lemeshow statistics, demonstrated that calibration was good with the unadjusted APACHE III ICU mortality model, and the APACHE III hospital mortality model adjusted for hospital characteristics. Post hoc analysis revealed a declining annual SMR (standardized mortality rate) during the study period. This trend was present in each of the non-surgical, emergency and elective surgical diagnostic groups, and the change was temporally related to increased specialist staffing levels.
Princess Alexandra Hospital (PAH) intensive care unit (ICU) provides medical and surgical critical care services to an 858 bed adult metropolitan hospital which is the regional centre for trauma, major surgery, medical sub-specialties, and psychiatry. In August 1994, the APACHE (Acute Physiology and Chronic Health Evaluation) III Management System 1 was introduced.
The APACHE III mortality estimates are part of a proprietary database and decision support system from APACHE Medical Systems, Inc. (Washington, U.S.A.). The risk equations and weights were developed by Knaus and colleagues 2 . The APACHE III score is an ICU severity of illness score calculated from the patient's age, presence of co-morbid conditions and the worst physiological and laboratory investigations in the first day. The APACHE III risk estimate equations use the admission diagnosis, the source of admission, lead-time to admission and the APACHE III score. The equations, but not the weights or co-efficients are in the public domain. The APACHE III system provides estimates of ICU and hospital risk of death. In addition to the generic models, the mortality predictions are adjusted for hospital characteristics, to allow comparison to similar hospitals in the American database. This is a different approach to that adopted by the familiar Australian and New Zealand Intensive Care database reports, where the APACHE II and SAPS II risk estimate models are not adjusted or recalibrated. Instead, mortality, SMR and demographic summaries are offered in the context of all other contributing Australian and New Zealand hospitals, and compared according to status as rural/regional, tertiary referral, metropolitan and private hospital ICU. The performance of the generic APACHE III first day hospital mortality predictions have been described on the developmental database 2 . In two large, prospective, multi-centre North American series (37,668 patients 3 and 116,340 patients 4 ) , the APACHE III model demonstrated good overall model performance. Subsequently, non-U.S.A. independent validation studies have shown good discrimination but poor agreement between predicted and observed hospital mortality outcomes [5] [6] [7] [8] [9] [10] .
The previous report from the PAH 10 describes the performance of the APACHE III ICU and hospital mortality models with adjustments for hospital characteristics. In the case of the PAH, the equations provide mortality estimates modelled on large American teaching hospitals from the original data set. The models where adjustments were made for the hospital characteristics were calibrated better than the unadjusted APACHE III models, though discrimination was the same. Since the previous report, an update to the APACHE III algorithm based on the accumulating database has been introduced, and a further two years experience has been gained with the APACHE III system.
Overall, the unadjusted APACHE III mortality prediction model has not performed well in clinical evaluation outside the U.S.A. where it was developed. As other local centres may consider introducing the APACHE III system, it is important to provide information about the local performance of the APACHE III proprietary models. The purpose of this study was to independently report on the performance characteristics of the APACHE III hospital and ICU mortality models, both unadjusted and with proprietary model adjustments, at the PAH in Brisbane.
MATERIALS AND METHODS
Admissions to the PAH ICU were studied from 1 January 1995 to 1 January 2000. Patients under 16 years of age, cardiac surgical and burns patients, and patients admitted for less than four hours or for consideration of myocardial infarction were excluded from the APACHE III predictions. Patient data were prospectively collected according to the rules of APACHE III 1,2 . Data were manually collected, or transferred from the pathology laboratory information system. The database manager verified all data. Outcomes were survival status on discharge from the ICU or the PAH. Patients transferred to rehabilitation facilities (spinal, geriatric, head injury and general rehabilitation units) or the psychiatric unit within the PAH complex were deemed in-patients, until discharged from the campus. Length of stay (LOS) in ICU and hospital was calculated as time from admission to discharge.
The study was conducted with the approval of the hospital research ethics committee, using deidentified data. Analysis was carried out using Excel'97 11 , Access'97 11 , Visual Basic 6.0 12 and Statistica 5.1 13 .
The ICU mortality models were assessed on all eligible admissions to ICU, including readmissions. Hospital mortality model assessment and hospital length of stay analysis excluded all ICU readmissions during an episode of hospitalization, to avoid double counting of outcomes.
For each admission, mortality estimates were provided by proprietary weights and the APACHE III equation 2 . For both in-ICU mortality and in-hospital mortality, the original APACHE III mortality model and a model with proprietary adjustments for hospital characteristics (similar hospital mortality model) were studied. The adjustments to allow comparison to similar U.S.A. hospitals include the additional data variables of pre-ICU treatment period (lead time) and information about the institution size, teaching status and region. In the case of the PAH, the similar hospital model references the predictions to large teaching hospitals in the Mid-West region of U.S.A. Equations and some diagnostic groups were revised at the end of 1998 as part of APACHE III review of model performance (letter to APACHE III users, 1998) and was based on a published review of the USA database 3 . The updated models were applied to the PAH data set from the beginning of 1999.
The aggregate predicted mortality rate for each model was the sum of estimated probabilities of death divided by the number of admissions. The standardized mortality ratio (SMR) was the ratio of observed mortality to the aggregate predicted mortality. Confidence intervals were estimated around the observed mortality, using exact limits for the binomial distribution 14 .
For assessment of model fit or calibration, the agreement between predicted and observed mortality rate in risk ranges was assessed. Calibration curves ( Figure 1 and 2) using 10 equal, contiguous risk ranges present observed against predicted outcomes with 95% confidence. The Hosmer-Lemeshow (H-L) statistics 15, 16 indicate the agreement between the observed and predicted mortality across risk ranges. For C*, admissions are ranked according to predicted risk of death and divided into 10 near equal groups. H* uses the sample divided into 10 contiguous deciles of risk of equal span, but unequal number. The C* and H* statistics are like a Pearson χ 2 statistic calculated from a 4 x 10 table of observed and estimated mortality and survival. For external validation studies, the degrees of freedom of the χ 2 distribution is the number of ranges of risk 16 . Rejection of the null hypothesis, that there is no difference between the predicted frequencies across the deciles of risk is at P<0.05. These statistics allow model performances to be compared if the same independent data set is used as the basis for comparison. A model with good calibration will have a lower χ 2 statistic and a higher P value, than a model with poor calibration.
Figures 1-4: Calibration curves for APACHE III mortality models showing calibration of observed mortality with 95% confidence intervals, plotted against expected mortality. Admissions are grouped in decile risk ranges according to mortality estimates. The dashed line is that of perfect agreement between observed and predicted mortality in all ranges.
Discrimination is a measure of the classification performance, and this ability to separate survivors from non-survivors was assessed by receiver operating characteristic (ROC) curve analysis. The area under the ROC curve estimates the probability that a randomly selected mortality will be given a higher risk of death estimate than a randomly chosen survivor. It is a global measure of the ability of the model to assign a higher risk of death to patients who die 17 . ROC area was calculated using trapezoidal areas and estimates were made of the standard error and confidence intervals 18 . An apparent decline in risk adjusted mortality prompted further post hoc analysis. Comparison of yearly casemix was performed using χ 2 statistics for categorical variables. Age and APACHE III score were analysed with non-parametric one way analysis of variance (Kruskal-Wallis) due to their non-normal frequency distribution. A liberal level of significance of P<0.05 was used to prompt further post hoc analysis between groups.
RESULTS
There were 5681 eligible episodes of ICU admission analysed. There were 5278 primary admissions and 403 (7.1%) readmissions. The demographic features of the patients are summarized in Table 2 .
The overall mortality was 515 deaths in ICU and 779 in hospital deaths from 5278 patient hospitalizations. The comparisons to the predicted mortality for the unadjusted APACHE III model and the model adjusted for hospital characteristics are presented in Table 3 . The area under the ROC curves for all models examined displayed excellent discrimination (Table 4 ). The calibration curves of the models are presented in Figures 1-4 and tabulated H-L statistics for each of the models in Table 5 . The calibration of the unadjusted APACHE III ICU mortality model is better than the ICU model adjusted for hospital characteristics (H* P: 0.28 v 0.05, C* P: 0.36 v 0.09), which tends to overestimate mortality in the mid risk ranges. The APACHE III model adjusted for hospital characteristics provides a better model fit that the generic APACHE III hospital mortality model (H* P: 0.68 v 0.002, C* P: 0.32 v 0.001).
The annual SMR with 95% confidence intervals for the similar hospital APACHE III mortality model is presented in Figure 5 . The hospital SMRs fell from 1.19 (1.02-1.36) in 1995 to 0.87 (0.75-1.02) in 1997, and have remained at 0.85 with the upper 95% confidence interval at 1.0.
The post hoc analysis was undertaken ( relative proportion of elective surgical cases increased during the period. Figure 6 displays the change in SMR seen with the three major diagnostic classes. For each class, there is a trend toward lower SMR. No further statistical analysis was undertaken due to the post hoc nature of this part of the study.
DISCUSSION
This paper reports the largest single institution prospective assessment of APACHE III outside the U.S.A. It provides updated information 10 about the performance of the APACHE III ICU and hospital mortality models with proprietary adjustments for hospital characteristics. It confirms that the APACHE III mortality models can have good discrimination and calibration in an Australian adult ICU population. This is the only institution reporting from a general ICU outside U.S.A. that endorses APACHE III model performance. It is consistent with the findings of previous reports from the U.K. 6,7 , Brazil 5 , Germany 8 and Australia 9,10 where the original, unadjusted hospital mortality model 2 performed poorly.
There is controversy about the best assessment of calibration of probablistic models of dichotomous outcomes. The reader is directed to reviews of the methodologies 17, [19] [20] [21] [22] [23] . The practical approach taken in this study is the graphical presentation of calibration Conclusions about model fit using the H-L statistics should be drawn in light of other relevant evidence and with consideration of limitations of the method. In this sample, the H-L analysis, the calibration curves and the global agreement between observed and predicted outcomes demonstrate that only the unadjusted APACHE III hospital mortality model had inadequate calibration. The H-L statistics are χ 2 -like statistics, so their absolute magnitude is not only dependent on the fit or calibration of the model, but on sample size and the distribution of the estimates 21 . A model assessed on a large patient sample tends to appear to fit less well than if assessed on a smaller sample drawn from the same population. These methods were developed for comparison of models on a common dataset 15 where patient numbers and distribution of mortality are controlled, as occurs during the modelling process. Therefore, in the present study, the generic and adjusted APACHE models can be directly compared, but performance cannot be compared where the same or different models are applied in different contexts. The absolute values of the statistics, or even the P values cannot be used as a basis for comparison to other studies, sites or samples.
An application of prospective, independent validation using χ 2 distributions with 10 degrees of freedom has been recommended 16, 20 and is used in this study. Validation studies use 10 degrees of freedom [24] [25] [26] [27] [28] or 8 degreees of freedom 3, 6, [29] [30] [31] . If the present analysis is repeated using 8 degrees of freedom, the P values are correspondingly smaller.
Discrimination of all APACHE III models was good (ROC curve area >0.8) or excellent (ROC curve area >0.9) 32 , approaching the proposed practical limit of this type of multivariate model 33 . The discrimination of the APACHE III model may be affected by case mix, clinical practice and data collection conditions. While most ROC areas for APACHE III are reported as >0.88 [2] [3] [4] 7 , some studies have found ROC area <0.86 (0.80 9 , 0.82 5 and 0.85 6, 8 ). However, generally, discrimination of the APACHE III system compares favourably with other hospital mortality predictions for ICU patients. The Mortality Probability Model II (MPM0 II) achieves ROC curve area of 0.74-0.84 27, 30, 32, 34 . The Simplified Acute Physiology System II has a ROC area of 0.82-0.85 on prospective validation samples 8, 27, 35 . APACHE II discrimination ranges between 0.79 and 0.89 8, 26, 30, 36, 37 . Organ System Failure Models 38, 39 perform well on developmental data sets, though prospective evaluation is limited.
The best model for prediction of in-ICU mortality on the series was the unadjusted APACHE III ICU mortality model. Both ICU mortality models had equal discrimination (ROC areas=0.91). The model adjusted for the hospital characteristics overestimated ICU mortality and the H-L statistics and calibration curves confirmed the better model fit for the unadjusted model. This is in contrast to a preliminary analysis of the first 3398 admissions of this series in which the APACHE III model adjusted for hospital characteristics performed better than the unadjusted model. In 1999, the ICU mortality model over estimated the observed mortality rate with the SMR (95% confidence intervals) of 0.77 (0.62-0.94). In contrast, the unadjusted model which provided a slightly lower estimate of probability of in-ICU death in 1999 (SMR (95% confidence intervals): 0.89 (0.72-1.09)).
The same trend is seen with the in-hospital mortality models. Both models have the same excellent discrimination, though the similar hospital mortality model is the better-calibrated model on the series (1995) (1996) (1997) (1998) (1999) . However, recent experience ( Figure 6 ) demonstrates that the similar hospital model consistently overestimates the patients risk of death at PAH. The SMR (95% confidence intervals) are 1998: 0.86 (0.72-1.00) and 1999: 0.85 (0.72-1.00). This is in contrast to 1995 (SMR 1.19) where the observed mortality was consistently higher than predicted. This change in model performance on the accumulating series accounts for differences in findings between the current analysis and previously published analysis of APACHE III predictions at the PAH 10 ICU. The timing of change in relative performance occurred over 1995-1996 ( Figure 5) , reaching a stable SMR 1997-1999. The increase in elective surgery occurred in 1998-1999 ( Table 6 ). The fall in SMR in all three major diagnostic groups (elective surgery, emergency surgery and non-operative cases) occurs from 1995.
This change in relative performance precedes the change in casemix, and the improvement across all diagnostic classes supports a global change in model fit. The same trends that are apparent in the similar hospital mortality model are found when this analysis is repeated with each of the APACHE III models over this period.
There is no mathematical way to apportion cause to changed model fit or to changed quality of care reflected in risk adjusted outcomes. Changes in data collection 40 , patient casemix 32 , mortality rate 34 and interpretations and transcription ambiguities 41 are proven to disrupt other ICU mortality prediction systems. The same factors that limit generalization of a model may cause drift in model fit over time. Changes in acute hospital discharge practices in the United States have been postulated to reduce the observed hospital mortality of ICU patients 4 .
The process of data collection and interpretation of variables and outcomes has remained constant throughout the five-year period of review. The casemix comparing the PAH patient samples and the APACHE III developmental database show that the PAH dataset is different to the developmental set 10 , being more commonly male, with a different mix of surgical and non-surgical diagnosis, and more comorbidities. Despite this, the models have displayed good discrimination and calibration. Subsequently, the casemix has altered, with an increase in the proportion of elective surgery, but each diagnostic class has relatively improved and contributed to the global fall in SMR.
There were significant changes in the process of ICU care during the period of study and may provide the best explanation for the fall in SMR over time. A closed model of intensive care, where trained critical care specialists are responsible for care of patients while they are in ICU was used throughout. However, the number of full time intensive care medical staff increased from 1.4 filled positions in 1995 to 5.3 in 1996 and remained from 1997-1999 at 4.6. The additional senior staff has allowed a comprehensive and ongoing multi-disciplinary review of clinical practices and procedures, according to the best evidence available and enhanced education and quality management program. This fall in SMR when staffing levels were improved supports the hypothesis that for a closed model of intensive care as practised at the PAH to be effective, adequate numbers of trained staff are an important factor.
CONCLUSION
This study demonstrates that the APACHE III model performs well on independent assessment in an Australian hospital. Changes observed in annual SMR using such a validated model support an hypothesis of improved survival outcomes 1995-1999.
